| Page 1265 | Kisaco Research
 

Eli Lilly vs Fresenius Kabi: A Continued Balancing Act for Doctrine of Equivalence?

Brian Coggio, Attorney, Fish & Richardson (USA)

Adrian Chew, Senior Associate, Bristows LLP (UK)

Daan De Laange, Partner, Brinkhof (NED)

Ewan Nettleton, Principal IP Counsel, Oncology Litigation, Novartis Pharma AG

Eli Lilly vs Fresenius Kabi: A Continued Balancing Act for Doctrine of Equivalence?

Eli Lilly vs Fresenius Kabi: A Continued Balancing Act for Doctrine of Equivalence?

Brian Coggio, Attorney, Fish & Richardson (USA)

Adrian Chew, Senior Associate, Bristows LLP (UK)

Daan De Laange, Partner, Brinkhof (NED)

Ewan Nettleton, Principal IP Counsel, Oncology Litigation, Novartis Pharma AG

 

Daniel Lim

Partner
Kirkland & Ellis

Daniel Lim

Partner
Kirkland & Ellis

Daniel Lim

Partner
Kirkland & Ellis
 

Strategic Consideration for Patent Portfolio Litigation

Mark van Gardingen, Partner, Brinkhof

Kristin Cooklin, Head of Intellectual Property, Zentiva

Dr Inga- Marlene Pietsch, Principal Associate, Gowling WLG (GBR)

Strategic Consideration for Patent Portfolio Litigation

Strategic Consideration for Patent Portfolio Litigation

Mark van Gardingen, Partner, Brinkhof

Kristin Cooklin, Head of Intellectual Property, Zentiva

Dr Inga- Marlene Pietsch, Principal Associate, Gowling WLG (GBR)

 

Discovering New Frontier for Second Medical Use Patent

Nitika Gupta Fiorella, Principal, Fish & Richardson (USA)

Tjibbe Douma, Partner, Bird & Bird (NED)

Tessa M. Malamud-Cohen, Director, Patents, Global Intellectual Property, Ferring Pharmaceuticals

Ewan Nettleton, Principal IP Counsel, Oncology Litigation, Novartis Pharma AG

Discovering New Frontier for Second Medical Use Patent

Discovering New Frontier for Second Medical Use Patent

Nitika Gupta Fiorella, Principal, Fish & Richardson (USA)

Tjibbe Douma, Partner, Bird & Bird (NED)

Tessa M. Malamud-Cohen, Director, Patents, Global Intellectual Property, Ferring Pharmaceuticals

Ewan Nettleton, Principal IP Counsel, Oncology Litigation, Novartis Pharma AG

 

Establishing a Successful Cross Border Relief Strategy

Cecile Teles, Head of Patent Attorney, Zentiva

Ricardo Dijkstra, Partner, Vondst (NED)

Establishing a Successful Cross Border Relief Strategy

Establishing a Successful Cross Border Relief Strategy

Cecile Teles, Head of Patent Attorney, Zentiva

Ricardo Dijkstra, Partner, Vondst (NED)

 

Divisional Patents Strategy: Safeguarding Innovation or Anti Competitive?

Rieke Kaup, DG Competition, European Commission

Sara Burghart, Lead IP Litigation Counsel – Global Litigation & Launch, Sandoz

Corinna Sundermann, Senior Vice President Intellectual Property, Fresenius Kabi Deutschland

Moderator: Stephan Neuhaus, Partner, Allen & Overy (DEU)

Divisional Patents Strategy: Safeguarding Innovation or Anti Competitive?

Divisional Patents Strategy: Safeguarding Innovation or Anti Competitive?

Rieke Kaup, DG Competition, European Commission

Sara Burghart, Lead IP Litigation Counsel – Global Litigation & Launch, Sandoz

Corinna Sundermann, Senior Vice President Intellectual Property, Fresenius Kabi Deutschland

Moderator: Stephan Neuhaus, Partner, Allen & Overy (DEU)

Animal Health USA Innovation Showcase Applicant Pack 2022
 

Dana Lucas

Director of Product & Partnerships
Good Face Project

Dana is the Director of Partnerships and Product at the Good Face Project, the industry’s fastest growing AI-powered ingredient transparency and innovation platform for Cosmetics and Personal Care. Dana specializes in translating demonstrated problems into products through human centered design, and by leveraging her background in business development, marketing, and applied design. Dana holds a BS in Marketing from Tulane University and an MPS in Design Management & Communications from Georgetown University.

Dana Lucas

Director of Product & Partnerships
Good Face Project

Dana Lucas

Director of Product & Partnerships
Good Face Project

Dana is the Director of Partnerships and Product at the Good Face Project, the industry’s fastest growing AI-powered ingredient transparency and innovation platform for Cosmetics and Personal Care. Dana specializes in translating demonstrated problems into products through human centered design, and by leveraging her background in business development, marketing, and applied design. Dana holds a BS in Marketing from Tulane University and an MPS in Design Management & Communications from Georgetown University.

 

Roxanne Ong

Head of Beauty Tech, Strategy & Education
Shiseido

Roxanne Ong is the Head of Beauty Tech, Strategy & Education of the Digital Transformation Office at the Shiseido Group.  Roxanne is responsible for the strategic development and delivery of innovations and technology that enables Consumer Engagement in the digital age. As Head of Education, Roxanne is also responsible for driving change in People and Organization as part of Shiseido’s Digital Transformation journey. 

Roxanne Ong

Head of Beauty Tech, Strategy & Education
Shiseido

Roxanne Ong

Head of Beauty Tech, Strategy & Education
Shiseido

Roxanne Ong is the Head of Beauty Tech, Strategy & Education of the Digital Transformation Office at the Shiseido Group.  Roxanne is responsible for the strategic development and delivery of innovations and technology that enables Consumer Engagement in the digital age. As Head of Education, Roxanne is also responsible for driving change in People and Organization as part of Shiseido’s Digital Transformation journey. 

A 20-plus year veteran of the digital space, Roxanne’s diverse professional experiences spans global corporations, tech start-ups and global consultancies across the beauty, education, travel, automotive and retail categories. She has held management positions across the CRM, Loyalty, Commerce, Branding disciplines at Estee Lauder Corporation, W Hotels, Ogilvy One, Hailo (now MyTaxi) and General Assembly.